Search
Safimaltib
go.drugbank.com/drugs/DB21528InvestigationalSafimaltib is under investigation in clinical trial NCT06788509 (A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring).
Izuforant
go.drugbank.com/drugs/DB21571ExperimentalThe usage of the INN stem '-forant' in the name indicates that Izuforant is a histamine H4 receptor antagonist. Izuforant has a monoisotopic molecular weight of 333.03 Da.
Inixaciclib
go.drugbank.com/drugs/DB21584ExperimentalThe usage of the INN stem '-ciclib' in the name indicates that Inixaciclib is a cyclin dependant kinase inhibitor. Inixaciclib has a monoisotopic molecular weight of 480.24 Da.
Abimtrelvir
go.drugbank.com/drugs/DB21596ExperimentalThe usage of the INN stem '-trelvir' in the name indicates that Abimtrelvir is a antiviral 3CL protease inhibitor. Abimtrelvir has a monoisotopic molecular weight of 527.11 Da.
Culmerciclib
go.drugbank.com/drugs/DB21600InvestigationalThe usage of the INN stem '-ciclib' in the name indicates that Culmerciclib is a cyclin dependant kinase inhibitor. Culmerciclib has a monoisotopic molecular weight of 446.23 Da.
Monzosertib
go.drugbank.com/drugs/DB21619InvestigationalThe usage of the INN stem '-sertib' in the name indicates that Monzosertib is a serine/threonine kinase inhibitor. Monzosertib has a monoisotopic molecular weight of 465.16 Da.
Votoplam
go.drugbank.com/drugs/DB21645InvestigationalThe usage of the INN stem '-plam' in the name indicates that Votoplam is a SMN2 gene splicing modulator. Votoplam has a monoisotopic molecular weight of 419.22 Da.
Potrasertib
go.drugbank.com/drugs/DB21682ExperimentalThe usage of the INN stem '-sertib' in the name indicates that Potrasertib is a serine/threonine kinase inhibitor. Potrasertib has a monoisotopic molecular weight of 564.19 Da.
Tigemocoxib
go.drugbank.com/drugs/DB21699ExperimentalThe usage of the INN stem '-coxib' in the name indicates that Tigemocoxib is a selective cyclo-oxygenase inhibitor. Tigemocoxib has a monoisotopic molecular weight of 334.06 Da.
Famitinib
go.drugbank.com/drugs/DB11741InvestigationalFamitinib has been used in trials studying the treatment of Colorectal Cancer, Renal Cell Cancer, Colorectal Cancer Recurrent, Colorectal Cancer Metastatic, and Metastatic Renal Cell Cancer, among others